Encore Dermatology Inc. Launches TridesilonTM (desonide) Cream, 0.05% for AD

01/16/2017
ReachMD Healthcare Image

Encore Dermatology Inc. is rolling out TridesilonTM (desonide) Cream, 0.05% in a 60g tube for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Encore Dermatology Inc. licensed TridesilonTM Cream, 0.05% from Perrigo Company plc. It is available in the U.S. by prescription only. TridesilonTM Cream, 0.05% should not be used for longer than two weeks unless directed by a physician. It is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

TridesilonTM Cream, 0.05% joins other Encore Dermatology products including HylatopicPlus® Cream or Lotion and Tetrix® Cream. TridesilonTM Cream, HylatopicPlus® and Tetrix® Cream are not indicated for combination use.

Register

We're glad to see you're enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free